Alector, Inc. (ALEC) stock
ALECNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$2.57+0.01 (+0.39%)
Close on Nov 18, 2026Market cap $286.96MP/E –Yield –
Alector shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Alector's shares outstanding was 111M at Jun 30, 2026. For fiscal 2025 it was 103M, up 6.6% from the year before. The highest annual figure on record is 103M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 103M | +6.6% |
| FY2024 | Dec 31, 2024 | 97M | +15.4% |
| FY2023 | Dec 31, 2023 | 84M | +1.5% |
| FY2022 | Dec 31, 2022 | 82M | +2.6% |
| FY2021 | Dec 31, 2021 | 80M | +3.4% |
| FY2020 | Dec 31, 2020 | 78M | +26.0% |
| FY2019 | Dec 31, 2019 | 62M | +446.2% |
| FY2018 | Dec 31, 2018 | 11M | +23.6% |
| FY2017 | Dec 31, 2017 | 9M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 111M | +10.8% |
| Q1 FY2026 | Mar 31, 2026 | 111M | +11.3% |
| Q4 FY2025 | Dec 31, 2025 | 110M | +11.5% |
| Q3 FY2025 | Sep 30, 2025 | 103M | +5.2% |
| Q2 FY2025 | Jun 30, 2025 | 100M | +3.8% |
| Q1 FY2025 | Mar 31, 2025 | 99M | +6.0% |
| Q4 FY2024 | Dec 31, 2024 | 98M | +16.5% |
| Q3 FY2024 | Sep 30, 2024 | 98M | +16.2% |
| Q2 FY2024 | Jun 30, 2024 | 97M | +15.7% |
| Q1 FY2024 | Mar 31, 2024 | 94M | +12.9% |
| Q4 FY2023 | Dec 31, 2023 | 84M | +2.0% |
| Q3 FY2023 | Sep 30, 2023 | 84M | +1.6% |
| Q2 FY2023 | Jun 30, 2023 | 84M | +1.2% |
| Q1 FY2023 | Mar 31, 2023 | 83M | +1.2% |
| Q4 FY2022 | Dec 31, 2022 | 83M | +13.3% |
| Q3 FY2022 | Sep 30, 2022 | 83M | -3.1% |
| Q2 FY2022 | Jun 30, 2022 | 83M | +3.5% |
| Q1 FY2022 | Mar 31, 2022 | 82M | +3.4% |
| Q4 FY2021 | Dec 31, 2021 | 73M | -7.5% |
| Q3 FY2021 | Sep 30, 2021 | 85M | +8.2% |
| Q2 FY2021 | Jun 30, 2021 | 80M | +1.8% |
| Q1 FY2021 | Mar 31, 2021 | 79M | +6.1% |
| Q4 FY2020 | Dec 31, 2020 | 79M | +16.3% |
| Q3 FY2020 | Sep 30, 2020 | 79M | +16.6% |
| Q2 FY2020 | Jun 30, 2020 | 78M | +16.5% |
| Q1 FY2020 | Mar 31, 2020 | 75M | +70.7% |
| Q4 FY2019 | Dec 31, 2019 | 68M | +478.4% |
| Q3 FY2019 | Sep 30, 2019 | 68M | +490.6% |
| Q2 FY2019 | Jun 30, 2019 | 67M | +503.5% |
| Q1 FY2019 | Mar 31, 2019 | 44M | +303.6% |
| Q4 FY2018 | Dec 31, 2018 | 12M | – |
| Q3 FY2018 | Sep 30, 2018 | 11M | – |
| Q2 FY2018 | Jun 30, 2018 | 11M | – |
| Q1 FY2018 | Mar 31, 2018 | 11M | – |
See a number that looks wrong?